Nitin Parekh

Nitin Parekh Email and Phone Number

President and CEO @ New York, NY, US
New York, NY, US
About Nitin Parekh

A global business executive, entrepreneur and industry leader with international multifunctional team building experience who possesses the ability to successfully implement strategic and tactical leadership for internal growth and partnering. Experienced in small and large molecules drug developments for startups, biotech and larger pharma companies leading to commercialization and growth of contract business. Skilled in managing P&L, leading and supervising teams, raise capital and understanding capital markets for technology and financial investment (VC, Private Equity and Independent Investors and Partners). Well experienced in executing corporate strategy for M&A activity portfolio. A proven leader in identifying partnering and acquisition of business, projects and targets in the areas of drug development and small molecule CDMO business development. Lead two large pharma manufacturing and CDMO acquisitions.

Nitin Parekh's Current Company Details
Espicor International

Espicor International

President and CEO
New York, NY, US
Nitin Parekh Work Experience Details
  • Espicor International
    President And Ceo
    Espicor International
    New York, Ny, Us
  • Espicor International
    President & Ceo
    Espicor International Apr 2023 - Present
    Strategic advisors to pharmaceutical, biotech & chemical industries. Provide mentoring, entrepreneur investing, board membership, drug development strategy, CDMO business growth, CMC and sourcing support. Corporate business strategies, private equity and M&A deals, alliance, partnership management and technology development. Evaluating commercial valuation of the enterprise.
  • Ten30 Biosciences (2024-Present),, Previously Anven Biosciences (2014-April 2024)
    Strategy Advisor, Team Member, Scientific And Business Advisory Boards
    Ten30 Biosciences (2024-Present),, Previously Anven Biosciences (2014-April 2024) Apr 2024 - Present
    Ten30 Bio leverages a comprehensive drug discovery platform to create oral therapeutics with specificity of peptides and benefits of small molecules. Our targeted protein degradation technology generates novel compounds to potentially treat Cancer, Neurological, Hematology and Autoimmune diseases.Anven Bioscience: Alzheimer, Parkinson, Cancer therapeutics development. Develop bi-functional orally administered molecules and effective therapeutics for targeted protein degradation.
  • Nj Institute Of Technology
    Advisory Board - Pre College Programs - Stem /Exec Committee Member-Ip & Enterprise & Licensing
    Nj Institute Of Technology Jan 2016 - Present
    Promote and support programs in science, technology, engineering and mathematics (STEM) for pre-college education - Jan 2016-Present/ Portfolio review, licensing and valuation, review inventions for targeted companies for licensing deals and commercialization -Jan 2016-Feb 2024.
  • Vybion, Inc.
    Management And Advisory Board- Present, Part-Time & Chief Business Officer-2004 - 1 Year
    Vybion, Inc. 1998 - Present
    Development of Drug for Huntington’s disease. Started as CDMO for Recombinant Protein Drug manufacturing and MAB catalogue business.
  • Sk Pharmteco
    Vp/Executive Director - Business Strategy, M&A And Business Development-Cdmo
    Sk Pharmteco Apr 2005 - Mar 2023
    Rancho Cordova , California, Us
    Significantly contributed in the growth of small molecule API and CDMO business from a revenue under $50 MM to over $700 million revenue. Actively led the team for two large acquisitions that put the company on the world map. Supported several biotech and large pharma companies in their drug development programs for CDMO and alliance management.
  • South Carolina Biotech Program (Sc Bio)
    Advisory Board Member
    South Carolina Biotech Program (Sc Bio) 2003 - 2010
    Cultivate life science companies providing assistance to start-up companies from universities in SC. Review viability of the technology and business plans, evaluate financials, established funding criteria, and support partner selection.
  • Dsm Pharma Chemicals/Dsm Pharma Products
    Vp North America/Vp Business & Technology Development
    Dsm Pharma Chemicals/Dsm Pharma Products Apr 1991 - Apr 2004
    Developed extensive market contacts. Participated significantly in the growth of CDMO business. Concluded API manufacturing deals with numerous companies such as Genzyme/Sanofi (anti-cholesterol drug), Merck (antibiotic), and BMS. He was a team member for the acquisition of Catalytica Pharma for DSM.
  • The Nutrasweet Co/Monsanto
    Business Group Leader/Sr. Scientist
    The Nutrasweet Co/Monsanto 1990 - 1991
    Part of the technology group to support business.
  • The Upjohn Co/ Pfizer
    Business & Technology Group Leader
    The Upjohn Co/ Pfizer 1985 - 1990
    Supported business with technology and product interaction.
  • Massachusetts Institute Of Technology
    Visiting Faculty/Sterling Drugs Staff Researcher
    Massachusetts Institute Of Technology 1986 - 1988
    Cambridge, Ma, Us
    Visiting faculty/staff at MIT, conducted research and provided guidance to Ph.D. students-1985-1987-Part time Staff Researcher-Sponsored by Sterling Drugs- Novel use of Enzyme Technology to manufacture Chiral Drugs -1984-1985 Full time

Nitin Parekh Skills

Bpo Technology Transfer Pharmaceutical Industry Drug Development Chemistry Lifesciences Gmp Strategy Biotechnology Commercialization Drug Discovery Life Sciences Organic Chemistry Clinical Development R&d Medicinal Chemistry Executive Management Regulatory Affairs Cro

Nitin Parekh Education Details

  • Massachusetts Institute Of Technology
    Massachusetts Institute Of Technology
  • Boston College
    Boston College
    Organic Chemistry

Frequently Asked Questions about Nitin Parekh

What company does Nitin Parekh work for?

Nitin Parekh works for Espicor International

What is Nitin Parekh's role at the current company?

Nitin Parekh's current role is President and CEO.

What is Nitin Parekh's email address?

Nitin Parekh's email address is n.****@****jit.edu

What is Nitin Parekh's direct phone number?

Nitin Parekh's direct phone number is +124064*****

What schools did Nitin Parekh attend?

Nitin Parekh attended Massachusetts Institute Of Technology, Boston College.

What skills is Nitin Parekh known for?

Nitin Parekh has skills like Bpo, Technology Transfer, Pharmaceutical Industry, Drug Development, Chemistry, Lifesciences, Gmp, Strategy, Biotechnology, Commercialization, Drug Discovery, Life Sciences.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.